Consonance Capital Management LP Macrogenics Inc Transaction History
Consonance Capital Management LP
- $7.28 Million
- Q3 2022
Shares
5 transactions
Others Institutions Holding MGNX
# of Institutions
143Shares Held
59.1MCall Options Held
143KPut Options Held
259K-
Bellevue Group Ag Kuesnacht, V89.94MShares$40.8 Million0.71% of portfolio
-
Armistice Capital, LLC New York, NY6MShares$24.6 Million0.33% of portfolio
-
Black Rock Inc. New York, NY5.4MShares$22.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.36MShares$17.9 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.31MShares$13.6 Million0.01% of portfolio
About MACROGENICS INC
- Ticker MGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,458,800
- Market Cap $252M
- Description
- MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...